Cause and Consequence of Cancer/Testis Antigen Activation in Cancer
- 6 January 2014
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 54 (1), 251-272
- https://doi.org/10.1146/annurev-pharmtox-011112-140326
Abstract
Tumor cells frequently exhibit widespread epigenetic aberrations that significantly alter the repertoire of expressed proteins. In particular, it has been known for nearly 25 years that tumors frequently reactivate genes whose expression is typically restricted to germ cells. These gene products are classified as cancer/testis antigens (CTAs) owing to their biased expression pattern and their immunogenicity in cancer patients. While these genes have been pursued as targets for anticancer vaccines, whether these reactivated testis proteins have roles in supporting tumorigenic features is less studied. Recent evidence now indicates that these proteins can be directly employed by the tumor cell regulatory environment to support cell-autonomous behaviors. Here, we review the history of the CTA field and present recent findings indicating that CTAs can play functional roles in supporting tumorigenesis.Keywords
This publication has 100 references indexed in Scilit:
- Small-Molecule Inhibition of BRDT for Male ContraceptionCell, 2012
- Loss of ASP but not ROPN1 reduces mammalian ciliary motilityCytoskeleton, 2011
- KNL1/Spc105 Recruits PP1 to Silence the Spindle Assembly CheckpointCurrent Biology, 2011
- Aire and T cell developmentCurrent Opinion in Immunology, 2011
- Deviant Kinetochore Microtubule Dynamics Underlie Chromosomal InstabilityCurrent Biology, 2009
- Mili Interacts with Tudor Domain-Containing Protein 1 in Regulating SpermatogenesisCurrent Biology, 2009
- Tdrd6 Is Required for Spermiogenesis, Chromatoid Body Architecture, and Regulation of miRNA ExpressionCurrent Biology, 2009
- Mouse Maelstrom, a Component of Nuage, Is Essential for Spermatogenesis and Transposon Repression in MeiosisDevelopmental Cell, 2008
- Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expressionCancer Immunology, Immunotherapy, 2008
- A gene trap knockout of the abundant sperm tail protein, outer dense fiber 2, results in preimplantation lethalitygenesis, 2006